FTO modifies the m6A level of MALAT and promotes bladder cancer progression

BACKGROUND: Nearly a half million people around the world are diagnosed with bladder cancer each year, and an incomplete understanding of its pathogenicity and lack of efficient biomarkers having been discovered lead to poor clinical management of bladder cancer. Fat mass and obesity‐associated prot...

Descripción completa

Detalles Bibliográficos
Autores principales: Tao, Le, Mu, Xingyu, Chen, Haige, Jin, Di, Zhang, Ruiyun, Zhao, Yuyang, Fan, Jie, Cao, Ming, Zhou, Zhihua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7851431/
https://www.ncbi.nlm.nih.gov/pubmed/33634966
http://dx.doi.org/10.1002/ctm2.310

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7851431/
https://www.ncbi.nlm.nih.gov/pubmed/33634966
http://dx.doi.org/10.1002/ctm2.310

Ejemplares similares